← Leaderboards
Suparna A Sarkar
University Of Colorado Denver
$245,145
Attributed
$245,145
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.5K · FY2008–09$200K$150K$100K$50K$0
'08
'09
Funding mix
By agency
NIH$245,145 · 1
By mechanism
K01$245,145 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Mamuka Kvaratskhelia$22,358,187
- Kelly D. Sullivan$6,280,565
- Boris Tabakoff$49,372,989
- Tracy L Bale$25,675,397
- Stephanie Anne Schittone$94,478
Others in their field
Top investigators on “Effector Cell”
- Michael S. Diamond · University Of Pittsburgh At Pittsburgh$45,507,937
- Rafi Ahmed · Emory University$40,549,730
- Louis J. Picker · Oregon Health And Science University$40,412,418
- Arlene H Sharpe · Harvard Medical School$39,916,440
- Jeffrey Victor Ravetch · Rockefeller University$35,982,041
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$33,132,961
Research focus
Effector CellAdenosine Diphosphate RiboseAntioxidantsAllogenicAutoimmune DiseasesAutoimmune ProcessBackBiologyCatabolismApoptoticCell DeathCell PhysiologyCellsCell SurvivalCell TypeCessation Of LifeCyclic Adp-RiboseCytokineCytotoxicDiabetes MellitusCell CountDioxygenasesDisorder ControlEnzymes
Grant awards (3)
Indoleamine 2, 3 dioxygenase signaling and function in Type 1 Diabetes$123,459
K01 · FY2009 · DK · contact PI
Indoleamine 2, 3 dioxygenase signaling and function in Type 1 Diabetes$1,080
K01 · FY2009 · DK · contact PI
Indoleamine 2, 3 dioxygenase signaling and function in Type 1 Diabetes$120,606
K01 · FY2008 · DK · contact PI